Conventionally, before eventually reaching clinical usage, product-based cancer treatments would take several decades and hundreds of million dollars of funding from pharmaceutical companies whose future profits rely solely on selling the products. LIFT, on the other hand, is very different since it is based on technologies rather than on products. Thus, it is highly unlikely that LIFT trial will be funded by conventional sources. A possible funding mechanism for conducting clinical trials to test LIFT is to gain grassroots support from charitable donations, direct support from trial participants and possibly the support of commercial entities that focus on developing technology-based treatments. If the trials successfully prove that LIFT can help increase patient lifespans, the treatments will be available at any hospital for only the cost of the medical procedure.
The trial estimated cost for each patient is more than $137,000. The efforts of raising funds for the US trial is an ongoing and yet slow process that has limited many patients’ participation in the trial. This process is the major obstacle to scientifically producing the data necessary to establish the efficacy of the LIFT. In the quest to speed up the acquisition of the data and hopefully bring this treatment to the masses, we have set up a trial (and hopefully soon more than one) in China where there is an abundance of cancer patients, cancer is the number-one killer in China, and medical procedures cost considerably lower than if the same procedure is performed in the US.
The cost for treating patients in the China trials is estimated to be significantly lower than that in the US trial. The lower cost should allow the speed of data acquisition to accelerate rapidly. If successful, it will help greatly to make the treatment available in all hospitals in China rapidly which will help mankind.
By conducting the trial in China, we are enabling international subjects to participate in the trial at a significantly reduced cost vs a trial in the US, even considering the additional travel costs to China. Of course, patients that participate in this trial must be willing to spend a minimum of one month in China, deal with partial language barriers, and adapt to a different type of hospital experience.
Breakdown of costs associated with the trial for each subject in China:
- Recruitment of donors
- Evaluation of donors (Over 25 donors tested for each patient)
- Donation Processing
- Doctor and Nurse Fees
- Testing including blood, MRIs, etc.
- Trial administration Costs
- Coordinator Costs